Keywords
Functional capacity
Muscle strength
Calcidiol
How to Cite
Abstract
Introduction: Vitamin D has beneficial effects that supposedly contribute to the maintenance of musculoskeletal function.
Objective: To analyze in an unselected population the effect of calcidiol levels on the muscular function of both hands, on the activities of daily living and on changes in bone mineral density (BMD).
Material and methods: The cohort of the EVOS study was used, which performed, among others, measurements of muscle strength of grasping both hands, questions related to the difficulty in performing daily activities, densitometric study of the lumbar and hip spine and biochemistry for determination calcidiol levels.
Results: Calcidiol values ≥20 ng / mL were associated with increased grip muscle strength in both hands. After adjusting for age, sex, BMI and seasonality, calcidiol levels <20 ng / mL were independently associated with decreased muscle grip strength only in the left hand (OR = 2.35, 95% CI 1.03 -5, 38) Likewise, the inability or difficulty in "picking up a book or object on a high shelf" and "getting out of bed" was significantly associated with calcidiol levels <20 ng / mL. Calcidiol levels <20 ng / mL were associated with greater losses of BMD in the femoral neck and in the total hip. These associations were maintained in the multivariate analysis.
Conclusions: The maintenance of calcidiol levels ≥20 ng / mL was associated with greater muscle grip strength in the hands, maintenance of daily activities and less loss of BMD in the hip. This study corroborates the usefulness of maintaining adequate levels of vitamin D to maintain musculoskeletal function.
References
Cederholm T, Cruz-Jentoft AJ, Maggi S. Sarcopenia and fragility fractures. Eur J Phys Rehabil Med. 2013;49:111-7.
Rizzoli R, Stevenson JC, Bauer JM, van Loon LJ, Walrand S, Kanis JA, et al. The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: A consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Maturitas. 2014;79:122-32.
Morgan KT. Nutritional determinants of bone health. J Nutr Elder. 2008;27:3-27.
Lips P, van Schoor NM. The effect of vitamin D on bone and osteoporosis. Best Pract Res Clin Endocrinol Metab. 2011;25:585-91.
Bischoff-Ferrari HA. Relevance of vitamin D in muscle health. Rev Endocr Metab Disord. 2012;13:71
Bolland MJ, Grey A, Avenell A. Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis. Lancet Diabetes Endocrinol. 2018;6:847-58.
Lips P. Vitamin D physiology. Prog Biophys Mol Biol. 2006;92:4-8.
Tieland M, Brouwer-Brolsma EM, Nienaber-Rousseau C, van Loon LJ, de Groot LC. Low vitamin D status is associated with reduced muscle mass and impaired physical performance in frail elderly people. Eur J Clin Nutr. 2013;67:1050-5.
Bischoff HA, Stahelin HB, Urscheler N, Ehrsam R, Vonthein R, Perrig-Chiello P, et al. Muscle strength in the elderly: Its relation to vitamin D metabolites. Arch Phys Med Rehabil. 1999;80:54-8.
Zamboni M, Zoico E, Tosoni P, Zivelonghi A, Bortolani A, Maggi S, et al. Relation between vitamin D, physical performance, and disability in elderly persons. J Gerontol A Biol Sci Med Sci. 2002;57:M7-11.
Wicherts IS, van Schoor NM, Boeke AJ, Visser M, Deeg DJ, Smit J, et al. Vitamin D status predicts physical performance and its decline in older persons. J Clin Endocrinol Metab. 2007;92:2058-65.
Snijder MB, van Schoor NM, Pluijm SM, van Dam RM, Visser M, Lips P. VitaminD status in relation to one-year risk of recurrent falling in older men and women. J Clin Endocrinol Metab. 2006;91:2980-5.
Stockton KA, Mengersen K, Paratz JD, Kandiah D, Bennell KL. Effect of vitamin D supplementation on muscle strength: A systematic review and meta-analysis. Osteoporos Int. 2011;22:859-71.
Howard GA, Turner RT, Sherrard DJ, Baylink DJ. Human bone cells in culture metabolize 25-hydroxyvitamin D3 to 1, 25-dihydroxyvitamin D3 and 24, 25-dihydroxyvitamin D3. J Biol Chem. 1981;256:7738-40.
van Driel M, Koedam M, Buurman CJ, Hewison M, Chiba H, Uitterlinden AG, et al. Evidence for auto/paracrine actions of vitamin D in bone: 1ahydroxylase expression and activity in human bone cells. FASEB J. 2006;20:2417-9.
Atkins GJ, Anderson PH, Findlay DM, Welldon KJ, Vincent C, Zannettino AC, et al. Metabolism of vitamin D3 in human osteoblasts: Evidence for autocrine and paracrine activities of 1a, 25-dihydroxyvitamin D3. Bone. 2007;40:1517-28.
van der Meijden K, Lips P, van Driel M, Heijboer AC, Schulten EA, den Heijer M, et al. Primary human osteoblasts in response to 25-Hydroxyvitamin D3, 1, 25-Dihydroxyvitamin D3 and 24R, 25-Dihydroxyvitamin D3. PLoS ONE. 2014;9:e110283.
Schwartz GG, Whitlatch LW, Chen TC, Lokeshwar BL, Holick MF. Human prostate cells synthesize 1, 25-dihydroxyvitaminD3 from 25-hydroxyvitaminD3. Cancer Epidemiol Biomarkers Prev. 1998;7:391-5.
Bacchetta J, Sea JL, Chun RF, Lisse TS, Wesseling-Perry K, Gales B, et al. Fibroblast growth factor 23 inhibits extrarenal synthesis of 1,25- dihydroxyvitamin D in human monocytes. J Bone Miner Res. 2013;28:46-55.
O´Neill TW, Cooper C, Algra D, Pols HAP, Agnusdei D, Dequeker J, et al, on behalf of the European Vertebral Osteoporosis Study Group. Design and development of a questionnaire for use in a multicentre study of vertebral osteoporosis in Europe: The European vertebral osteoporosis study (EVOS). Rheumatol Eur. 1995;24:75-81.
O'Neill TW, Cooper C, Cannata JB, Diaz Lopez JB, Hoszowski K, Johnell O, et al, on behalf of the European Vertebral Osteoporosis Study (EVOS) Group. Reproducibility of a questionnaire on risk factors for osteoporosis in a multicentre prevalence survey: the European Vertebral Osteoporosis Study. Int J Epidemiol. 1994;23:559-65.
Gómez Alonso C. Valores de la densidad mineral ósea (BMD) en columna lumbar y cadera de la población sana española. En: Díaz Curiel M, Díez Pérez A, Gómez Alonso C, FHOEMO-SEIOMM-RPR (eds). Nuevas fronteras en el estudio de la densidad ósea en la población española. Madrid: Rhone Poulenc Rorer; 1996. p. 73-94.
Girgis CM, Clifton-Bligh RJ, Hamrick MW, Holick MF, Gunton JE. The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr Rev. 2013;34:33-83.
Barbonetti A, D´Andrea S, Martorella A, Felzani G, Francavilla S, Francavilla F. Low vitamin D levels are independent predictors of 1-year worsening in physical function in people with chronic spinal cord injury: a longitudinal study. Spinal Cord. 2018;56:494-501.
Nicoletti Gumieiro D, Murino Rafacho BP, Buzati Pereira BL, Alvisi Cavallari K, Erico Tanni S, Schmidt Azevedo P, et al. Vitamin D serum levels are associated with handgrip strength but not with muscle mass or length of hospital stay after hip fracture. Nutrition. 2015;31:931-4.
Visser M, Deeg DJH, Lips P. Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): The Longitudinal Aging Study Amsterdam. J Clin Endocrinol Metab. 2003;88:5766 e 5772.
Arbex Borim FS, da Silva Alexandre T, Liberalesso Neri A, de Oliveira Máximo R, Fernandes Silva M, de Oliveira C. Combined effect of dynapenia (muscle weakness) and low vitamin D status on incident disability. J Am Med Dir Assoc. 2019;20:47-52.
Sohl E, van Schoor NM, de Jongh RT, Visser M, Deeg DJH, Lips P. Vitamin D status is associated with functional limitations and functional decline in older individuals. J Clin Endocrinol Metab. 2013;98:E1483-90.
Verreault R, Semba RD, Volpato S, Ferrucci L, Fried LP, Guralnik JM. Low serum vitamin D does not predict new disability or loss of muscle strength in older women. J Am Geriatr Soc. 2002;50: 912-7.
Bischoff-Ferrari HA, Dietrich T, Orav EJ, Dawson-Hughes B. Positive association between 25-hydroxy vitamin D levels and bone mineral density: a population-based study of younger and older adults. Am J Med. 2004;116:634-9.
Reid IR, Bolland MJ, Grey A. Effects of 2014 vitamin D supplements on bone mineral density: a systematic review and meta-analysis. Lancet. 2014;383:146-55.
Montoya MJ, Vázquez MA, Miranda C, Miranda MJ, Pérez-Cano R, Giner M. Influencia de la vitamina D sobre la microestructura y propiedades biomecánicas de pacientes con fractura de cadera. Rev Osteoporos Metab Miner. 2017;9:121-9.
Gómez C, Naves ML, Barrios Y, Díaz JB, Fernández JL, Salido E, et al. Vitamin D receptor gene polymorphisms, bone mass, bone loss and prevalence of vertebral fracture: differences in postmenopausal women and men. Osteoporos Int. 1999;10:175-82.
Naves M, Díaz-López JB, Gómez C, Rodríguez-Rebollar A, Rodríguez-García M, Cannata-Andía JB. The effect of vertebral fracture as a risk factor for osteoporotic fracture and mortality in a Spanish population. Osteoporos Int. 2003;14:520-4.
Naves M, Díaz-López JB, Gómez C, Rodríguez-Rebollar A, Serrano-Arias M, Cannata-Andía JB. Prevalence of osteoporosis in men and determinants of changes in bone mass in a non-selected Spanish population. Osteoporos Int. 2005;16:603-9.
Naves M, Díaz-López JB, Gómez C, Rodríguez-Rebollar A, Cannata-Andía JB. Determinants of incidence of osteoporotic fractures in the female Spanish population older than 50. Osteoporos Int. 2005;16:2013-7.
Naves M, Rodríguez-García M, Díaz-López JB, Gómez-Alonso C, Cannata-Andía JB. Progression of vascular calcifications is associated with greater bone loss and increased bone fractures. Osteoporos Int. 2008;19:1161-6.
Naves-Díaz M, Cabezas-Rodríguez I, Barrio-Vázquez S, Fernández E, Díaz-López JB, Cannata-Andía JB. Low calcidiol levels and risk of progression of aortic calcification. Osteoporos Int. 2012;23:1177-82.
Tuñón-Le Poultel D, Cannata-Andía JB, Román-García P, Díaz-López JB, Coto E, Gómez C, et al. Association of matrix Gla protein gene functional polymorphisms with loss of bone mineral density and progression of aortic calcification. Osteoporos Int. 2014;25:1237-46.
Este artigo é uma cópia com adaptação para o português do Artigo Original "Gómez Alonso, C., et al. "Niveles de calcidiol y mantenimiento de la función muscular, capacidad funcional y densidad mineral ósea en población española no seleccionada." Revista de Osteoporosis y Metabolismo Mineral 11.1 (2019): 6-11." Esta Cópia com adaptação para o Português segue os preceitos Creative Commons CC BY 4.0 ( https://creativecommons.org/licenses/by/4.0/deed.pt_BR ) disponibilizado pelo periódico responsável pela publicação original ( http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1889-836X2019000100002&lng=es&nrm=iso&tlng=es ).
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2019 Authors